Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record

byiShook Opinion
Oct 14, 2024 - 13:35

Share

Lundbeck announced Monday it would buy Longboard Pharmaceuticals in a $2.6 billion deal that sent Longboard stock to a record high. The post Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record appeared first on Investor's Business Daily.

Lundbeck announced Monday it would buy Longboard Pharmaceuticals in a $2.6 billion deal that sent Longboard stock to a record high.

The post Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record appeared first on Investor's Business Daily.